4.5 Review

Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: A systematic review and meta-analysis

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation and Concomitant Liver Cirrhosis: A Systematic Review and Meta-Analysis

Zhi-Yan Lee et al.

Summary: Retrospective studies have shown that the use of DOACs in patients with AF and liver cirrhosis is associated with a significant reduction in the risk of ischemic stroke, major bleeding events, and intracranial hemorrhage.

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2022)

Review Medicine, General & Internal

Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis

Danilo Menichelli et al.

Summary: The study found that the use of DOACs in patients with liver disease or cirrhosis significantly reduced the incidence of major bleeding and intracranial hemorrhage, as well as recurrence of vein thrombosis. However, there was no impact on mortality and ischemic stroke/systemic embolism.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Gastroenterology & Hepatology

Evaluation of the efficacy and safety of direct oral anticoagulants in the treatment of portal vein thrombosis

Haley N. Ilcewicz et al.

Summary: The study demonstrated that direct oral anticoagulants are effective and safe in treating portal vein thrombosis and preventing recurrent thromboembolic events, with fewer failure and safety events compared to warfarin treatment. Further research with larger sample sizes is needed to confirm the efficacy of direct oral anticoagulants in portal vein thrombosis.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)

Wei Fen Xie et al.

Summary: This expert consensus systematically reviews the epidemiology, risk factors, imaging examinations, diagnosis, assessment of disease severity, and treatment strategy of portal vein thrombosis in liver cirrhosis, based on the most recent evidence and expert opinions, to further standardize the diagnosis and treatment of the disease in clinical practice.

JOURNAL OF DIGESTIVE DISEASES (2021)

Review Hematology

Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis

Emanuele Valeriani et al.

Summary: Anticoagulant therapy shows positive effects on vein recanalization and progression, major bleeding, and overall mortality in cirrhotic patients with SVT, but the incidence of recurrent VTE remains substantial.

THROMBOSIS AND HAEMOSTASIS (2021)

Review Cardiac & Cardiovascular Systems

Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis

Sarah A. Nisly et al.

Summary: Several studies have shown that there is no significant difference in major bleeding events between traditional anticoagulation and DOACs in patients with cirrhosis, suggesting that the risk of using DOACs in this patient population is similar to that of traditional anticoagulation.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Gastroenterology & Hepatology

Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis

Huan Chen et al.

Summary: Anticoagulation therapy is effective and relatively safe for treating or preventing portal vein thrombosis in patients with liver cirrhosis. Direct oral anticoagulants are more effective and safer than traditional anticoagulants, and multiple use of enoxaparin in small doses is safer than single large doses.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Medicine, General & Internal

Practical use of Direct Oral Anti Coagulants (DOACs) in the older persons with atrial fibrillation

Mario Bo et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)

Article Gastroenterology & Hepatology

Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation

Yan Zhang et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes

Kyle A. Davis et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

Article Gastroenterology & Hepatology

S1085 Direct Oral Anticoagulants and Warfarin in Patients With Cirrhosis and Portal Vein Thrombosis: A Comparison of Outcomes

Joel Joseph et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Article Cardiac & Cardiovascular Systems

Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study

Elena Campello et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Gastroenterology & Hepatology

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta-Analysis

Francesco Violi et al.

HEPATOLOGY COMMUNICATIONS (2020)

Review Gastroenterology & Hepatology

Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis

Nicolas M. Intagliata et al.

GASTROENTEROLOGY (2019)

Review Medicine, General & Internal

Safety of direct oral anticoagulants in patients with cirrhosis: a systematic review and meta-analysis

K. Lapumnuaypol et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2019)

Review Gastroenterology & Hepatology

Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate

Mariella Faccia et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

Anticoagulation in the cirrhotic patient

Laura Turco et al.

JHEP REPORTS (2019)

Review Cardiac & Cardiovascular Systems

Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis

Natale Daniele Brunetti et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2018)

Article Medicine, General & Internal

Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function

Bernhard Scheiner et al.

WIENER KLINISCHE WOCHENSCHRIFT (2018)

Review Hematology

Direct oral anticoagulants in patients with liver cirrhosis: A systematic review

Evert Willian Hoolwerf et al.

THROMBOSIS RESEARCH (2018)

Review Gastroenterology & Hepatology

Changing Concepts of Cirrhotic Coagulopathy

Armando Tripodi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Hematology

The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis

Justine Hum et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2017)

Article Gastroenterology & Hepatology

Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis

Filipe Nery et al.

GASTROENTEROLOGY RESEARCH (2017)

Article Gastroenterology & Hepatology

Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation

N. M. Intagliata et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Review Hematology

Hemostasis abnormalities in cirrhosis

Armando Tripodi

CURRENT OPINION IN HEMATOLOGY (2015)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Vascular diseases of the liver

JOURNAL OF HEPATOLOGY (2015)

Meeting Abstract Gastroenterology & Hepatology

GASTROINTESTINAL ISCHEMIA IN PATIENTS WITH ACUTE AND CHRONIC PORTAL VEIN THROMBOSIS

J. Harki et al.

JOURNAL OF HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Splanchnic vein thrombosis and variceal rebleeding in patients with cirrhosis

Lucio Amitrano et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis

Erica Villa et al.

GASTROENTEROLOGY (2012)

Article Medicine, General & Internal

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Medicine, General & Internal

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Gastroenterology & Hepatology

Systematic review: portal vein thrombosis in cirrhosis

E. A. Tsochatzis et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)

Editorial Material Public, Environmental & Occupational Health

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Andreas Stang

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)

Article Gastroenterology & Hepatology

Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-up Study

Aurelie Plessier et al.

HEPATOLOGY (2010)

Article Gastroenterology & Hepatology

Portal Vein Thrombosis and Liver Transplant Survival Benefit

Michael J. Englesbe et al.

LIVER TRANSPLANTATION (2010)

Letter Hematology

Definition of major bleeding used by US anticoagulation clinics

Anna Seto et al.

THROMBOSIS RESEARCH (2009)